What this study is
The overall aim of this research is to utilize wound derived inflammatory cells from diabetic versus non diabetic human chronic wounds to understand mechanisms that are responsible for disregulated inflammation in individuals with diabetes. Biology of normal (peripheral blood derived cells) versus wound derived cells will also be studied.
What's being tested
- Blood draw
Intervention · OTHER
Blood will be drawn from subjects once and VAC sponge will be collected (which is normally discarded material per standard of care).
Study details
- Official title
- Mechanisms Underlying Impaired Wound Healing
- Sponsor
- University of Pittsburgh
- Conditions
- Non-healing Wound
- Enrolling
- 250 people
- Starts
- 2008-09-01
- Est. completion
- 2030-12-31
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 21 Years – 80 YearsSex ALLHealthy volunteers Not acceptedYou may qualify if
- Ages 21-80
- Chronic Wound (present >4 weeks)
- Diabetic & Non-diabetic
- Adult surgical wounds
You can't join if
- Inability to consent
- Pregnant women
- Therapeutically immunocompromised
- Individuals defined in 45 CFR 46 Subparts B,C, and D, nor from any other population considered vulnerable 2.9
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (2)
2 openUPMC Montefiore
Pittsburgh, Pennsylvania, United States
- CeCe Zamarripa, RN · Contact412-647-7728zamarripaca@upmc.edu
- Piya Das Ghatak, PhD · Contact4126240422piya.dasghatak@pitt.edu
RecruitingUPMC Presbyterian
Pittsburgh, Pennsylvania, United States
- Cecilia Zamarripa, RN · Contact412-647-7728zamarripaca@upmc.edu
- Piya Das Ghatak, PhD · Contact412-648-8297pid12@pitt.edu
Recruiting
Study team
Sponsor
University of Pittsburgh
Study ID STUDY23070132
Principal investigator
Sashwati Roy, Ph.D.
University of Pittsburgh
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.